AstraZeneca COVID drug neutralises Omicron sub-variants in lab study
Submitted by mike kraft on
AstraZeneca COVID drug neutralises Omicron sub-variants in lab study AstraZeneca said on Monday its antibody-based cocktail to prevent and treat COVID-19 retained neutralising activity against Omicron coronavirus variants, including the highly contagious BA.2 sub-variant, in an independent lab study. Reuters
Country / Region Tags:
Problem, Solution, SitRep, or ?: